Analysis of stem cell collections in adult patients with Ewing sarcoma.

Georg-Nikolaus FrankeRoald PfannesSimone HeynMandy BrücknerSusanne RieprechtEnrica BachYvonne RemaneSabine LeibleinWolfram PönischDietger NiederwieserSebastian SchwindUwe PlatzbeckerMadlen JentzschVladan Vucinic

Published in: Transfusion (2022)

Stem cell mobilization is feasible in most Ewing sarcoma patients. Additionally, the present study's data suggest that it is safe to postpone stem cell collection to a later VIDE chemotherapy cycle if medically indicated.

Keyphrases

stem cells
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
cell therapy
prognostic factors
peritoneal dialysis
electronic health record
radiation therapy
big data
mesenchymal stem cells
patient reported